세포배양 배지 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 종류별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Culture Media Market Summary

The global cell culture media market size was estimated at USD 4.75 billion in 2025 and is projected to reach USD 12.80 billion by 2033, growing at a CAGR of 13.54% from 2026 to 2033. Cell culture media are generally in a liquid or powdered format that includes compounds required to regulate and support the growth of cells or microorganisms used in the manufacturing of biopharmaceuticals.

Market growth is driven by the rising production of biopharmaceuticals and cell-based vaccines, along with increasing adoption of cell-based research in cancer, regenerative medicine, and stem cell therapy. Advancements in bioprocessing technologies, including serum-free media and single-use systems, are further supporting demand and accelerating market expansion.

Global Cell Culture Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global cell culture media market report based on the product, application, type, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Serum-free Media
  • CHO Media
  • BHK Medium
  • Vero Medium
  • HEK 293 Media
  • Other Serum-free media
• Classical Media
• Stem Cell Culture Media
  • Mesenchymal Stem Cells (MSCs)
  • Hematopoietic Stem Cells (HSCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Other Stem Cells
• Immunology Media
  • T Cells
  • B Cells
  • Natural Killer (NK) Cells
  • Other Immune Cells
• Specialty Media
• Chemically Defined Media
• Other Cell Culture Media
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
• Diagnostics
• Drug Screening and Development
• Tissue Engineering and Regenerative Medicine
  • Cell and Gene Therapy
  • Other Tissue Engineering and Regenerative Medicine Applications
• Other Applications
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Liquid Media
• Semi-solid and Solid Media
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Other End Uses
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Type
  • 1.2.4. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Expansion of biosimilars and biologics
    • 3.3.1.2. Growth in stem cell research
    • 3.3.1.3. Emerging cell culture technologies for cell-based vaccines
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. Ethical issues concerning the use of animal-derived products
    • 3.3.2.2. Stringent regulatory guidelines
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Cell Culture Media Market Product, Movement Analysis
• 4.3. Global Cell Culture Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Serum-free Media
  • 4.4.1. Global serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. CHO Media
    • 4.4.2.1. Global CHO media market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.4.3. HEK 293 media
    • 4.4.3.1. Global HEK 293 media market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.4.4. BHK media
    • 4.4.4.1. Global BHK media market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.4.5. Vero medium
    • 4.4.5.1. Global vero medium market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.4.6. Other serum-free media
    • 4.4.6.1. Global other serum-free media market estimates and forecasts, 2021 - 2033 (USD million)
• 4.5. Classical Media
  • 4.5.1. Global classical media market estimates and forecasts, 2021 - 2033 (USD million)
• 4.6. Stem Cell Culture Media
  • 4.6.1. Global stem cell culture media market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.6.2. Mesenchymal Stem Cells (MSCs)
    • 4.6.2.1. Mesenchymal Stem Cells (MSCs) market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.6.3. Hematopoietic Stem Cells (HSCs)
    • 4.6.3.1. Hematopoietic Stem Cells (HSCs) market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.6.4. Induced Pluripotent Stem Cells (iPSCs)
    • 4.6.4.1. Induced Pluripotent Stem Cells (iPSCs) market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.6.5. Other Stem Cells
    • 4.6.5.1. Other Stem Cells market estimates and forecasts, 2021 - 2033 (USD million)
• 4.7. Immunology Media
  • 4.7.1. Global immunology media market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.7.2. T Cells
    • 4.7.2.1. T Cells market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.7.3. B Cells
    • 4.7.3.1. B Cells market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.7.4. Natural Killer (NK) Cells
    • 4.7.4.1. Natural Killer (NK) Cells market estimates and forecasts, 2021 - 2033 (USD million)
  • 4.7.5. Other Immune Cells
    • 4.7.5.1. Other Immune Cells market estimates and forecasts, 2021 - 2033 (USD million)
• 4.8. Chemically Defined Media
  • 4.8.1. Global chemically defined media market estimates and forecasts, 2021 - 2033 (USD million)
• 4.9. Specialty Media
  • 4.9.1. Global speciality media market estimates and forecasts, 2021 - 2033 (USD million)
• 4.10. Other Cell Culture Media
  • 4.10.1. Global other cell culture media market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 5. Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Cell Culture Media Market Type, Movement Analysis
• 5.3. Global Cell Culture Media Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Liquid Media
  • 5.4.1. Global liquid media market estimates and forecasts, 2021 - 2033 (USD million)
• 5.5. Semisolid & Solid Media
  • 5.5.1. Global semi-solid & solid media market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Cell Culture Media Market Application, Movement Analysis
• 6.3. Global Cell Culture Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Biopharmaceutical Production
  • 6.4.1. Global biopharmaceutical production market estimates and forecasts, 2021 - 2033 (USD million)
  • 6.4.2. Monoclonal antibodies
    • 6.4.2.1. Global monoclonal antibodies market estimates and forecasts, 2021 - 2033 (USD million)
  • 6.4.3. Vaccines production
    • 6.4.3.1. Global vaccines production market estimates and forecasts, 2021 - 2033 (USD million)
  • 6.4.4. Other therapeutic proteins
    • 6.4.4.1. Global other therapeutic proteins market estimates and forecasts, 2021 - 2033 (USD million)
• 6.5. Diagnostics
  • 6.5.1. Global diagnostics market estimates and forecasts, 2021 - 2033 (USD million)
• 6.6. Drug Screening & Development
  • 6.6.1. Global drug screening & development market estimates and forecasts, 2021 - 2033 (USD million)
• 6.7. Tissue Engineering & Regenerative Medicine
  • 6.7.1. Global tissue engineering & regenerative medicine market estimates and forecasts, 2021 - 2033 (USD million)
  • 6.7.2. Cell & gene therapy
    • 6.7.2.1. Global cell & gene therapy market estimates and forecasts, 2021 - 2033 (USD million)
  • 6.7.3. Other tissue engineering & regenerative medicine
    • 6.7.3.1. Global other tissue engineering & regenerative medicine market estimates and forecasts, 2021 - 2033 (USD million)
• 6.8. Other Applications
  • 6.8.1. Global other applications market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Cell Culture Media Market End Use, Movement Analysis
• 7.3. Global Cell Culture Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Global pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD million)
• 7.5. Hospitals & Diagnostic Laboratories
  • 7.5.1. Global hospitals & diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD million)
• 7.6. Research & Academic Institutes
  • 7.6.1. Global research & academic institutes market estimates and forecasts, 2021 - 2033 (USD million)
• 7.7. Other End Use
  • 7.7.1. Global other End Use market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 8. Cell Culture Media Market: Regional Estimates and Trend Analysis, by Product, Type, Application, & End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America cell culture media market, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. cell culture media market, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada cell culture media market, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico cell culture media market, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden cell culture media market, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway cell culture media market, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand cell culture media market, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea cell culture media market, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America cell culture media market, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil cell culture media market, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina cell culture media market, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE cell culture media market, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait cell culture media market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. Sartorius AG
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Danaher
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Merck KGaA
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Thermo Fisher Scientific, Inc.
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. FUJIFILM Corporation
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Lonza
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. BD
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. STEMCELL Technologies
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Cell Biologics, Inc.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. PromoCell GmbH
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives